Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 15.34
+0.84 (5.79%)
At close: Mar 27, 2026
Laekna Market Cap
Laekna has a market cap or net worth of 6.42 billion as of March 27, 2026. Its market cap has increased by 29.50% in one year.
Market Cap
6.42B
Enterprise Value
5.15B
Revenue
118.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.34
Market Cap Chart
Since June 29, 2023, Laekna's market cap has increased from 5.85B to 6.42B, an increase of 9.64%. That is a compound annual growth rate of 3.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 6.06B | 6.85% |
| Dec 31, 2025 | 5.68B | 62.12% |
| Dec 31, 2024 | 3.50B | -54.90% |
| Dec 29, 2023 | 7.76B | 32.67% |
| Jun 29, 2023 | 5.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Haohai Biological Technology | 9.06B |
| CARsgen Therapeutics Holdings | 8.89B |
| Abbisko Cayman | 8.01B |
| Alphamab Oncology | 7.50B |
| CK Life Sciences Int'l., (Holdings) | 6.44B |
| Ocumension Therapeutics | 5.68B |
| Jacobio Pharmaceuticals Group | 5.15B |
| Beijing Luzhu Biotechnology | 4.58B |